You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

The Role of Neurokinin-1 Receptor Antagonists in the Prevention of Emesis due to High-dose Cisplatin

ID: 12-4 Apr 2005
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
D. Warr, T. Oliver, Systemic Treatment Disease Site Group